Vaishali Pharma Limited (VAISHALI) — Cash Flow-to-Debt Ratio
Vaishali Pharma Limited (VAISHALI) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of Rs20.46 Million could theoretically repay 0% of its total liabilities (Rs545.40 Million) in one year. Check VAISHALI cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vaishali Pharma Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Vaishali Pharma Limited across 13 annual periods. Also explore VAISHALI total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Vaishali Pharma Limited (2013–2025)
Year-by-year debt coverage analysis for Vaishali Pharma Limited. For market capitalisation and broader financial context, see VAISHALI market cap.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.40x | Rs-180.38 Million | Rs449.29 Million | ▼ -1947.2% |
| 2024 | 0.02x | Rs8.07 Million | Rs371.16 Million | ▼ -22.7% |
| 2023 | 0.03x | Rs10.80 Million | Rs383.76 Million | ▲ +17.9% |
| 2022 | 0.02x | Rs13.19 Million | Rs552.70 Million | ▼ -24.4% |
| 2021 | 0.03x | Rs20.11 Million | Rs637.05 Million | ▼ -56.0% |
| 2020 | 0.07x | Rs32.19 Million | Rs448.23 Million | ▲ +19.4% |
| 2019 | 0.06x | Rs28.48 Million | Rs473.52 Million | ▲ +127.8% |
| 2018 | -0.22x | Rs-94.60 Million | Rs437.22 Million | ▼ -1135.9% |
| 2017 | 0.02x | Rs8.52 Million | Rs407.80 Million | ▼ -78.8% |
| 2016 | 0.10x | Rs45.88 Million | Rs465.19 Million | ▲ +213.0% |
| 2015 | -0.09x | Rs-37.16 Million | Rs425.60 Million | ▲ +37.5% |
| 2014 | -0.14x | Rs-70.40 Million | Rs503.56 Million | ▼ -268.7% |
| 2013 | 0.08x | Rs37.97 Million | Rs458.09 Million | — |